Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings
Authors
Keywords
Pharmacogenomics, Thailand, Clinical decision support, Electronic health records (EHR), Precision medicine
Journal
Drug Metabolism and Pharmacokinetics
Volume -, Issue -, Pages 100399
Publisher
Elsevier BV
Online
2021-05-05
DOI
10.1016/j.dmpk.2021.100399
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacogenomics at the center of precision medicine: challenges and perspective in an era of Big Data
- (2020) Dragan Primorac et al. PHARMACOGENOMICS
- Clinical Genome Data Model (cGDM) provides Interactive Clinical Decision Support for Precision Medicine
- (2020) Hyo Jung Kim et al. Scientific Reports
- Genetic association of co‐trimoxazole‐induced severe cutaneous adverse reactions is phenotype‐specific: HLA class I genotypes and haplotypes
- (2020) Chonlaphat Sukasem et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children
- (2020) Wiparat Manuyakorn et al. EPILEPSY RESEARCH
- NUDT15 genetic variants are related to thiopurine-induced neutropenia in Thai children with acute lymphoblastic leukemia
- (2020) Apichaya Puangpetch et al. PHARMACOGENOMICS
- Pharmacogenetic associations and evidence-based pharmacogenomics guidelines: supporting label and off-label use of drug–gene interaction data
- (2020) David F Kisor et al. PHARMACOGENOMICS
- Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy
- (2020) Chalirmporn Atasilp et al. Scientific Reports
- Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population
- (2020) Chalitpon Na nakorn et al. Frontiers in Pharmacology
- Pharmacogenomics and Personalized Medicine
- (2020) Erika Cecchin et al. Genes
- Genome-Wide Association Study Confirming the Association of NAT2 with Susceptibility to Anti-tuberculosis Drug–Induced Liver Injury in Thai Patients
- (2019) Supharat Suvichapanich et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacogenomics guidelines: Current status and future development
- (2019) Chengxian Guo et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Clinical Pharmacogenetics Implementation Consortium ( CPIC ) Guideline for CYP 2B6 and Efavirenz‐containing Antiretroviral Therapy
- (2019) Zeruesenay Desta et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenomics
- (2019) Dyson T. Wake et al. MEDICAL CLINICS OF NORTH AMERICA
- A stepwise approach to implementing pharmacogenetic testing in the primary care setting
- (2019) Kristin Wiisanen Weitzel et al. PHARMACOGENOMICS
- Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand
- (2018) Passara Jongkhajornpong et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Education and Knowledge in Pharmacogenomics: Still a Challenge?
- (2018) Jyothsna Giri et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome
- (2018) Dan M. Roden et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
- (2018) Elizabeth J. Phillips et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
- (2018) Katharina Schwarze et al. GENETICS IN MEDICINE
- Genetic polymorphisms of HTR2C ,LEP and LEPR on metabolic syndromes in patients treated with atypical antipsychotic drugs
- (2018) Apichaya Puangpetch et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Impact of POR and CYP3A5 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in the Early Post-Operative Period Following Kidney Transplantation
- (2018) Annop Phupradit et al. THERAPEUTIC DRUG MONITORING
- Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients
- (2018) Chonlaphat Sukasem et al. Journal of Immunology Research
- HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population
- (2018) Nontaya Nakkam et al. Frontiers in Genetics
- Current landscape of personalized medicine adoption and implementation in Southeast Asia
- (2018) Huey Yi Chong et al. BMC Medical Genomics
- Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions
- (2017) Kittika Yampayon et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of CYP2D6 Polymorphism on Steady-State Plasma Levels of Risperidone and 9-Hydroxyrisperidone in Thai Children and Adolescents with Autism Spectrum Disorder
- (2017) Natchaya Vanwong et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Pharmacogenomics: Precision Medicine and Drug Response
- (2017) Richard M. Weinshilboum et al. MAYO CLINIC PROCEEDINGS
- Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now
- (2017) Kristin W. Weitzel et al. PHARMACEUTICAL RESEARCH
- Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population
- (2017) Niwat Saksit et al. Pharmacogenetics and Genomics
- Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13
- (2017) Therdpong Tempark et al. Pharmacogenetics and Genomics
- Pharmacogenomics in Asia: a systematic review on current trends and novel discoveries
- (2017) Hazel Xiaohui Ang et al. PHARMACOGENOMICS
- Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population
- (2017) Napatrupron Koomdee et al. Frontiers in Pharmacology
- HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis
- (2017) Kanoot Jaruthamsophon et al. Scientific Reports
- Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges
- (2016) MJ Arwood et al. CTS-Clinical and Translational Science
- A prospective observational study of CYP2C19 polymorphisms and voriconazole plasma level in adult Thai patients with invasive aspergillosis
- (2016) Sumonrat Chuwongwattana et al. Drug Metabolism and Pharmacokinetics
- Correlation of UGT1A1 * 28 and * 6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients
- (2016) Chalirmporn Atasilp et al. Drug Metabolism and Pharmacokinetics
- On the Potential of Preemptive Genotyping Towards Preventing Medication-Related Adverse Events: Results from the South Korean National Health Insurance Database
- (2016) Jonathan S. Schildcrout et al. DRUG SAFETY
- Association of HLA genotypes with phenobarbital hypersensitivity in children
- (2016) Wiparat Manuyakorn et al. EPILEPSIA
- Multidisciplinary model to implement pharmacogenomics at the point of care
- (2016) Pedro J. Caraballo et al. GENETICS IN MEDICINE
- NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients
- (2016) S. Wattanapokayakit et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
- (2016) James M Hoffman et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population
- (2016) Wichittra Tassaneeyakul et al. Pharmacogenetics and Genomics
- A success story in pharmacogenomics: genetic ID card for SJS/TEN
- (2016) Chonlaphat Sukasem et al. PHARMACOGENOMICS
- Assessment of pharmacogenetic tests: presenting measures of clinical validity and potential population impact in association studies
- (2016) E C M Tonk et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenomic Study Reveals New Variants of Drug Metabolizing Enzyme and Transporter Genes Associated with Steady-State Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Thai Autism Spectrum Disorder Patients
- (2016) Sadeep Medhasi et al. Frontiers in Pharmacology
- HLA-B*58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand
- (2016) Chonlaphat Sukasem et al. Frontiers in Pharmacology
- Thailand’s universal coverage scheme and its impact on health-seeking behavior
- (2016) Seung Chun Paek et al. SpringerPlus
- Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
- (2015) Henry M. Dunnenberger et al. Annual Review of Pharmacology and Toxicology
- Association analysis of CYP2C9*3 and phenytoin-induced severe cutaneous adverse reactions (SCARs) in Thai epilepsy children
- (2015) Supharat Suvichapanich et al. JOURNAL OF HUMAN GENETICS
- Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions
- (2015) Thachanan Kongpan et al. Pharmacogenetics and Genomics
- Whole genome sequencing in pharmacogenomics
- (2015) Theodora Katsila et al. Frontiers in Pharmacology
- Clinical pharmacogenetics implementation: Approaches, successes, and challenges
- (2014) Kristin W. Weitzel et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- Prerequisites to Implementing a Pharmacogenomics Program in a Large Health-Care System
- (2014) K D Levy et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics and Clinical Biomarkers for Subtherapeutic Plasma Efavirenz Concentration in HIV-1 Infected Thai Adults
- (2014) Chonlaphat Sukasem et al. Drug Metabolism and Pharmacokinetics
- Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing
- (2014) Yuan Xue et al. GENETICS IN MEDICINE
- Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population
- (2014) Surasak Saokaew et al. PLoS One
- Clinical Application of Pharmacogenomics: The Example of HLA-Based Drug-Induced Toxicity
- (2014) Ming Ta Michael Lee et al. Public Health Genomics
- Genetics and genomics in Thailand: challenges and opportunities
- (2014) Vorasuk Shotelersuk et al. Molecular Genetics & Genomic Medicine
- Impact of CYP2D6 Polymorphisms on Tamoxifen Responses of Women with Breast Cancer: A Microarray-based Study in Thailand
- (2013) Chonlaphat Sukasem et al. Asian Pacific Journal of Cancer Prevention
- High Plasma Efavirenz Concentration and CYP2B6 Polymorphisms in Thai HIV-1 Infections
- (2013) Chonlaphat Sukasem et al. Drug Metabolism and Pharmacokinetics
- CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy
- (2013) Weerawat Manosuthi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Implementation and outcomes of a live continuing education program on pharmacogenomics
- (2013) Grace M Kuo et al. PHARMACOGENOMICS
- Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists
- (2013) Rachel Mills et al. PHARMACOGENOMICS
- Impact of Pharmacogenetic Markers of CYP2B6, Clinical Factors, and Drug-Drug Interaction on Efavirenz Concentrations in HIV/Tuberculosis-Coinfected Patients
- (2012) W. Manosuthi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults
- (2012) Chonlaphat Sukasem et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Drug Reimbursement Decision-Making in Thailand, China, and South Korea
- (2012) Surachat Ngorsuraches et al. VALUE IN HEALTH
- Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
- (2012) Camilla Stephens et al. Frontiers in Genetics
- Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
- (2010) Wichittra Tassaneeyakul et al. EPILEPSIA
- Impact of the heterozygous TPMT1/3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand
- (2009) Suda Vannaprasaht et al. CLINICAL THERAPEUTICS
- Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population
- (2009) Wichittra Tassaneeyakul et al. Pharmacogenetics and Genomics
- Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
- (2008) Chaichon Locharernkul et al. EPILEPSIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now